Discover how mini-proteins deliver targeted radiation to Nectin-4 expressing tumor cells, sparing healthy tissues and offering new hope for cancer...

Despite significant advancements in cancer treatment, drug resistance remains a persistent challenge. Cancer cells can often develop resistance to...

A team of scientists has uncovered a mechanism by which ovarian cancer tumors evade immunotherapy. They've also pinpointed a potential drug target...

Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with...

Mini-proteins are engineered protein capsule, bcapable of delivering targeted radiation dose directly to tumor cells expressing Nectin-4/b. ...

Recently, a collaborative research team led by Prof. Wang Hui and Prof. Qian Junchao from the Hefei Institutes of Physical Science of the Chinese...

A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in...

Mohali’s Homi Bhabha Cancer Hospital and Research Centre (HBCHRC) sees patients from Punjab, Haryana, Himachal Pradesh, Jammu & Kashmir and even...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...

HER2-targeted therapies, originally developed for breast cancer, may also benefit patients with rare bile duct cancer and HER2-mutated breast...